Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Pharmacodynamic Models: Logarithmic Concentration–Effect Model01:15

Pharmacodynamic Models: Logarithmic Concentration–Effect Model

The log-linear model is a pharmacological framework used to describe the relationship between drug concentration and its effect. This model is particularly relevant when the observed effects range between 20% and 80% of the drug’s maximum effect (Emax), where a near-linear relationship is observed between the log of drug concentration and the measured effect. However, the log-linear model does not predict the maximum possible effect (Emax) or the effect at zero drug concentration, limiting its...
Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models00:57

Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models

Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modeling quantifies in vivo neutralization, Fc-mediated killing, and resistance in human clinical trials of five anti-HIV broadly neutralizing antibodies.

bioRxiv : the preprint server for biology·2026
Same author

Towards modeling phage therapy.

PLoS computational biology·2026
Same author

INHERITANCE OF INTRACELLULAR VIRAL RNA IN A MULTISCALE MODEL OF HEPATITIS C INFECTION.

SIAM journal on applied mathematics·2026
Same author

AZD5582 robustly reactivates latently infected cells and clears the majority of those reactivated from the SIV reservoir.

bioRxiv : the preprint server for biology·2026
Same author

Bemnifosbuvir: An HCV NS5B Inhibitor With Multiple Modes of Action.

Clinical pharmacology and therapeutics·2026
Same author

Analysis of blood proteome in influenza-infected patients reveals new insights into the host response signatures distinguishing mild severe infections.

Frontiers in immunology·2025

Related Experiment Video

Updated: Jun 5, 2026

Monitoring Influenza Virus Survival Outside the Host Using Real-Time Cell Analysis
09:02

Monitoring Influenza Virus Survival Outside the Host Using Real-Time Cell Analysis

Published on: February 20, 2021

Influenza A virus infection kinetics: quantitative data and models.

Amber M Smith1, Alan S Perelson

  • 1Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM, USA.

Wiley Interdisciplinary Reviews. Systems Biology and Medicine
|January 4, 2011
PubMed
Summary

Mathematical models help understand influenza A virus infection dynamics. These models analyze viral growth and decay, offering insights into host-pathogen interactions and potential treatments for influenza.

More Related Videos

Influenza A Virus Studies in a Mouse Model of Infection
10:44

Influenza A Virus Studies in a Mouse Model of Infection

Published on: September 7, 2017

Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses
09:07

Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses

Published on: January 20, 2017

Related Experiment Videos

Last Updated: Jun 5, 2026

Monitoring Influenza Virus Survival Outside the Host Using Real-Time Cell Analysis
09:02

Monitoring Influenza Virus Survival Outside the Host Using Real-Time Cell Analysis

Published on: February 20, 2021

Influenza A Virus Studies in a Mouse Model of Infection
10:44

Influenza A Virus Studies in a Mouse Model of Infection

Published on: September 7, 2017

Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses
09:07

Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses

Published on: January 20, 2017

Area of Science:

  • Systems biology
  • Virology
  • Mathematical modeling

Background:

  • Influenza A virus is a significant public health threat, causing seasonal epidemics and pandemics.
  • Understanding host-pathogen interactions is crucial for developing effective influenza treatments.
  • Viral kinetic models offer a quantitative approach to study influenza infection dynamics.

Purpose of the Study:

  • To review recent viral kinetic models for influenza.
  • To demonstrate how these models provide insights into influenza pathogenesis and treatment.
  • To highlight challenges in viral kinetic analysis.

Main Methods:

  • Discussion of recent viral kinetic models.
  • Analysis of model applications in understanding influenza.
  • Identification of challenges in model formulation and data collection.

Main Results:

  • Viral kinetic models can summarize complex influenza data.
  • Models have been instrumental in understanding influenza pathogenesis.
  • Models aid in evaluating potential treatment strategies for influenza.

Conclusions:

  • Kinetic modeling is a valuable tool for studying influenza virus and host interactions.
  • Accurate model formulation and comprehensive data are essential for robust analysis.
  • Further development in viral kinetic analysis can lead to improved influenza control strategies.